LONCAR INVESTMENTS
The Loncar Cancer Immunotherapy Index (LCINDX) seeks to track the performance of a transformational therapeutic field within the biotechnology space. Biotech stocks tend to get grouped together as a whole, yet areas like immunotherapy trade on their own unique circumstances and innovations. The goal of the Cancer Immunotherapy index is to give investors a better understanding of the immunotherapy sector by highlighting major companies involved and providing a metric to track their progress. They hope that highlighting immunotherapy in this fashion will lead to more awareness within the investment community, more investment in the field, and more progress for patients who battle cancer disease.
LONCAR INVESTMENTS
Social Links:
Industry:
Biotechnology
Founded:
2015-03-18
Address:
Lenexa, Kansas, United States
Country:
United States
Website Url:
http://www.loncarfunds.com
Total Employee:
1+
Status:
Active
Contact:
(913) 871-5007
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro Wix Comments Plugin For Wix
Similar Organizations
Minutia
Biotech, Therapeutics
Current Employees Featured
Founder
Official Site Inspections
http://www.loncarfunds.com
- Host name: 162.255.119.33
- IP address: 162.255.119.33
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Loncar Investments"
Loncar Investments - Crunchbase Company Profile & Funding
The Loncar Cancer Immunotherapy Index (LCINDX) seeks to track the performance of a transformational therapeutic field within the biotechnology space.See details»
Loncar Investments - Overview, News & Competitors - ZoomInfo
View Loncar Investments (www.loncarfunds.com) location in Kansas, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50
Feb 16, 2018 Loncar Investments is an official partner of the Cancer Research Institute (CRI), the world’s longest running nonprofit organization dedicated exclusively to harnessing the …See details»
Loncar Investments Selects Cancer Research Institute as Exclusive ...
Founded in 1953, the Cancer Research Institute is the world’s only non-profit organization dedicated to harnessing immunotherapy to conquer cancer. The partnership is a two-year …See details»
loncarfunds.com - Whois.com
Whois Lookup for loncarfunds.com. Domain Services Transfer your Domain Consolidate your domains quickly & easily Free With Every Domain Get over $100 worth of free servicesSee details»
www.loncarfunds.com
Www.loncarfunds.comSee details»
Loncar Cancer Immunotherapy ETF - ltse.com
Compliance and supervisory personnel should note that, among other things, this PIC discusses the need to deliver a prospectus to customers purchasing shares of the ETP listed above. …See details»
Cancer-Fighting Stocks & ETF: What You Need to Know - Yahoo …
Jun 5, 2019 To learn more about these ETFs, please visit loncarfunds.com. Please also visit the Cancer Research Institute to learn about this cancer treatment and clinical trials.See details»
Loncar Investments - Company Information, Competitors, News
Find useful insights on Loncar Investments's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Loncar Investments.See details»
Loncar Holdings Inc. Company Profile | Calgary, AB, Canada ...
Find company research, competitor information, contact details & financial data for Loncar Holdings Inc. of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»
Why Cancer-Fighting Stocks & ETFs Are Soaring - Yahoo Finance
Jun 3, 2019 UN predicts world economic growth at subdued 2.8% in 2025. The world economy resisted battering by conflicts and inflation last year and is expected to grow a subdued 2.8% …See details»
Investors Exchange Product Information Circular 2018 - 0128
Information Circular to interested persons within your organization. Exchange-Traded Fund Symbol Loncar China BioPharma ETF CHNA Issuer/Trust: ETF Series Solutions Issuer/Trust …See details»
Loncar Funds - Vimeo
PLEASE READ THE PROSPECTUS BEFORE INVESTING (See links left for Prospectus, Important Disclosures, Holdings and Website). Loncar Funds specializes in creating precise…See details»
Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) (CNCR)
Find the latest Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) (CNCR) discussion and analysis from iHub's community of investors.See details»
CNCR – Range Cancer Therapeutics ETF – ETF Stock Quote
Nov 30, 2024 CNCR – Range Cancer Therapeutics ETF – Check CNCR price, review total assets, see historical growth, and review the analyst rating from Morningstar.See details»
Loncar Cancer Immunotherapy ETF - placera.se
Feb 16, 2018 The Loncar Cancer Immunotherapy ETF (Nasdaq: CNCR) recently surpassed $50 million in assets under management (AUM), marking a pivotal milestone for the fund.. …See details»
Loncar Cancer Immunotherapy ETF Fund factsheet | Trustnet
The latest fund information for Loncar Cancer Immunotherapy ETF, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information.See details»
Loncar Cancer Immunotherapy ETF (CNCR) Surpasses $50 Million …
Feb 16, 2018 OKLAHOMA CITY--(BUSINESS WIRE)-- The Loncar Cancer Immunotherapy ETF (Nasdaq: CNCR) recently surpassed $50 million in assets under management (AUM), marking …See details»
@LoncarFunds | X
The latest posts from @LoncarFundsSee details»
Welcome to Fundcars
Welcome to Fundcars A Better Way to Fund Auto Loans. Read Whitepaper . FundCars © 2017-2024 FundCars — Made in California.See details»